Sale of 7,452 Nucor (NUE) shares planned under Rule 144

Rhea-AI Filing Summary

Nucor Corporation has a holder planning to sell 7,452 shares of its common stock under Rule 144. The shares are to be sold through Merrill Lynch on the NYSE, with an aggregate market value of 1,460,438.41 and 228,858,659 shares outstanding.

The securities were acquired as restricted stock compensation from Nucor on 06/01/2024, in three grants totaling 7,452 shares, with payment also dated 06/01/2024. The notice states the seller represents they do not know of any undisclosed material adverse information about Nucor’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 1301 Gervais St, Suite 1500 Columbia SC 29072	7452	1460438.41	228858659	02/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/01/2024	Restricted Stock	Nucor Corporation			3282	06/01/2024	Compensation
Common Stock	06/01/2024	Restricted Stock	Nucor Corporation			239	06/01/2024	Compensation
Common Stock	06/01/2024	Restricted Stock	Nucor Corporation			3931	06/01/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Nucor (NUE) disclose in this Form 144 filing?

The filing shows a holder plans to sell 7,452 Nucor common shares under Rule 144. The sale will occur through Merrill Lynch on the NYSE, with an aggregate market value of 1,460,438.41 and 228,858,659 shares outstanding.

How many Nucor (NUE) shares are planned for sale and where will they trade?

The notice covers 7,452 Nucor common shares planned for sale. They are to be sold through Merrill Lynch on the NYSE, with an aggregate market value of 1,460,438.41 as disclosed in the Rule 144 filing.

How were the Nucor (NUE) shares in this Form 144 acquired?

The shares were acquired as restricted stock compensation from Nucor on 06/01/2024. Three grants of 3,282, 239, and 3,931 shares were received, each paid on 06/01/2024, totaling 7,452 shares covered by the planned Rule 144 sale.

What does the seller represent about Nucor (NUE) in this Form 144?

The seller represents they do not know any material adverse information about Nucor’s current or prospective operations that has not been publicly disclosed. This representation is made by signing the Form 144 notice for the planned sale.

What is the aggregate market value of the Nucor (NUE) shares to be sold?

The filing lists an aggregate market value of 1,460,438.41 for the 7,452 Nucor common shares to be sold. This figure is tied to the planned Rule 144 sale on the NYSE through Merrill Lynch.

When is the planned sale date for the Nucor (NUE) shares in this Form 144?

The approximate sale date disclosed is 02/11/2026. On or around this date, 7,452 Nucor common shares are planned for sale on the NYSE through Merrill Lynch, subject to Rule 144 conditions and market execution.